Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
about
Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cellsvia suppression of PGE2 and deactivation of Wnt/β-catenin signaling pathway.CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissues.
P2860
Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Methotrexate and 5-aminoimidaz ...... and hepatocellular carcinoma.
@en
Methotrexate and 5-aminoimidaz ...... and hepatocellular carcinoma.
@nl
type
label
Methotrexate and 5-aminoimidaz ...... and hepatocellular carcinoma.
@en
Methotrexate and 5-aminoimidaz ...... and hepatocellular carcinoma.
@nl
prefLabel
Methotrexate and 5-aminoimidaz ...... and hepatocellular carcinoma.
@en
Methotrexate and 5-aminoimidaz ...... and hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Methotrexate and 5-aminoimidaz ...... r and hepatocellular carcinoma
@en
P2093
P2860
P2888
P304
P356
10.1038/APS.2013.16
P577
2013-04-22T00:00:00Z